http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106750047-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F4-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F290-062
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F290-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F4-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
filingDate 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106750047-B
titleOfInvention Preparation method of pH-responsive adriamycin nano-drug capsule with positive surface charge
abstract The invention relates to a preparation method of a pH-responsive adriamycin nano-drug capsule with positive surface charges, which comprises the steps of uniformly mixing adriamycin nano-drug particles with acrylate groups modified on the surfaces with a certain amount of neutral monomer Acrylamide (AM), positively charged monomer N- [3- (dimethylamino) propyl ] methacrylamide (DMAPMA) and a pH-responsive degradation cross-linking agent in deionized water, adding a redox initiator ammonium persulfate/Tetramethylethylenediamine (TEMED) to initiate in-situ free radical polymerization, and dialyzing, freezing and drying to obtain the adriamycin nano-drug capsule. By changing the type of the cross-linking agent, adjusting the dosage of the monomer and the cross-linking agent and the like, the adriamycin nano-drug capsule with smaller average particle size, uniform dispersion, higher dissolution rate, larger dissolution rate and the like and better performance can be obtained. The method provides a new idea and selection, is simple to operate, and can realize the precise control of the structure and the surface of the adriamycin nano capsule and the efficient delivery in vivo.
priorityDate 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19076217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415766857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426414956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414874081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410565041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452434431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9942690

Total number of triples: 58.